Aspira Women's Health Inc AWH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
6.93UNCH (UNCH)
Volume
22,489
Close
6.93quote price arrow down-0.13 (-1.84%)
Volume
478,215
52 week range
0.53 - 10.54

...

Loading . . .

KEY STATS

  • Open7.08
  • Day High7.47
  • Day Low6.80
  • Prev Close7.06
  • 52 Week High10.54
  • 52 Week High Date01/29/21
  • 52 Week Low0.53
  • 52 Week Low Date03/16/20
  • Market Cap773.11M
  • Shares Out111.56M
  • 10 Day Average Volume0.66M
  • Dividend-
  • Dividend Yield-
  • Beta3.15
  • 1 Year % Change704.88

RATIOS/PROFITABILITY

  • EPS (TTM)-0.15
  • P/E (TTM)-45.15
  • Fwd P/E (NTM)-40.76
  • EBITDA (MRQ)-15.076M
  • ROE (MRQ)-115.34%
  • Revenue (MRQ)4.51M
  • Gross Margin (MRQ)33.70%
  • Net Margin (MRQ)-337.05%
  • Debt To Equity (MRQ)14.80%

EVENTS

  • Earnings Date03/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Aspira Women's Health Inc News

There is no recent news for this security.

Latest AWH News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Aspira Women’s Health Inc., formerly Vermillion, Inc., is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. The Company sells OVA1, Overa and OVA1PLUS risk of malignancy tests for ovarian cancer. The Company also sells a product for genetic testing for specific women’s health diseases, called ASPiRA GenetiX, with a core focus on ovarian cancer. OVA1 is a blood test designed to, in addition to a physician’s clinical assessment...
James LaFrance
Chairman
Valerie Palmieri
President
Robert Beechey
Chief Financial Officer
Address
Suite 100
12117 Bee Caves Road Building Three
Austin, TX
78738
United States